Acrux Ltd has released a press release.
FDA Approval - Nitroglycerin Ointment
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Acrux
- Trading Halt
- AGM Presentation
- FY24 R&D Tax Incentive rebate received
- ASX Small and Mid Cap Conference presentation
- FY24 Full Year Results - Investor Presentation
Later from Acrux
- Share Placement successfully concluded and SPP launched
- Investor Presentation
- Share Purchase Plan Offer Booklet
- Commercialisation of Nitroglycerin Ointment
- Investor Deck update, SPP Closes 18 December 2024, 5pm
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux